Your daily biotech briefing: top newsflow, market moves, and deal flow—all in one place and without the fluff
Dec 5, 2025
•
1 min read
FDA leadership churn and vaccine politics, ACIP punts again, plus fresh CNS, oncology and kidney data.
Dec 4, 2025
Former FDA chiefs revolt, Capricor redeems its DMD play, user fees target ex-US Phase 1—and XBI jumps.
Dec 3, 2025
Pazdur exits, FDA trims monkey studies, WuXi faces Pentagon list; biotech lags while GLP-1s keep reshaping the board
Dec 2, 2025
Vaccine-policy drama hits sentiment, UK pays up to dodge tariffs, Lilly trims Zepbound prices again as XBI/NBI slide.
